Aman Khera discusses the importance of diversity and inclusion in clinical research, and how collaboration can help overcome obstacles of diversity.

In this Applied Clinical Trials blog, Aman Khera shares her perspective on CTTI’s vision for the future of clinical trials, and how COVID-19 has impacted the industry.

Watch Aman Khera speak at Sarepta’s panel on diversity and inclusion in the biopharma industry. She shares her perspective on strategies to advance D&I.

Avoid the pitfalls of last-minute FDA study requests through smart planning. Read this case study for strategies to submit an NDA on time.

With significant variations in the effects of COVID-19 among various ethnic, racial, and minority groups, how do we ensure vaccine trials are accurately establishing efficacy and safety across all patient populations? Beyond the ethical considerations, diversity is a medical and scientific imperative. This peer-reviewed article identifies tools and considerations for achieving representative diversity in enrolment for COVID-19 vaccine registration trials.

Read this article about findings from the most recent Biopharma Confidence Index that show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence.